ACTU
Actuate Therapeutics, Inc.
0.62$
-15.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 100.0% | 81.1% | 31.8% | 100.0% | 98.8% | 94.8% | 96.0% | 98.5% | 97.2% | 95.6% | 91.3% | |
| – | 98.8% | 76.6% | 20.3% | 94.8% | 92.7% | 86.8% | 93.2% | 95.5% | 93.8% | 91.3% | 85.1% | |
| – | 98.8% | 76.6% | 20.3% | 94.8% | 92.7% | 86.8% | 93.2% | 95.5% | 93.8% | 91.3% | 85.1% | |
| – | 3,425.8% | 4,093.7% | 6,701.3% | 62.4% | 98.9% | 213.5% | 138.1% | 38.3% | 43.5% | 57.5% | 81.0% | |
| – | 231.0% | 546.0% | 1,159.7% | 59.6% | 94.5% | 204.2% | 132.0% | 36.0% | 40.7% | 53.0% | 73.2% | |
| – | – | 185.3% | 398.7% | – | – | – | – | – | – | – | – | |
| – | 114.2% | 146.6% | 340.5% | 16.3% | 20.6% | 59.0% | 45.5% | 7.0% | 10.9% | 13.5% | 20.7% | |
| – | -3,325.8% | -3,993.7% | -6,601.3% | 37.6% | 1.1% | -113.5% | -38.1% | 61.7% | 56.5% | 42.5% | 19.0% | |
| – | -3,508.3% | -4,201.9% | -6,931.0% | -883.0% | -1,420.6% | -3,093.8% | -2,075.6% | -847.1% | -1,101.5% | -1,798.1% | -3,175.4% | |
| – | 509.5% | 574.0% | 1,128.5% | 136.8% | 209.4% | 434.9% | 281.9% | 120.8% | 165.6% | 264.1% | 459.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.